Incyte (NASDAQ:INCY) today announced that multiple abstracts featuring new data from the company's clinical program on povorcitinib, an investigational oral JAK-1 inhibitor, have been accepted for oral presentation at
The Allstate Corporation (NYSE:ALL) today announced estimated catastrophe losses for the month of July of $313 million or $247 million, after-tax.
July month catastrophe losses include 18 events estimated
Goldman Sachs Group has revised its year-end target for the S&P 500 Index to 5,600, up from the previous 5,200. The adjustment is attributed to the robust earnings growth of five major U.S. tech companies and an increased fair value price-to-earnings ratio.